Staff Physician, Head and Neck Surgical Oncology
Division of Otolaryngology, Brigham and Women’s Hospital/Dana-Farber Cancer Institute, Boston, MA; Department of Otolaryngology, Harvard Medical School, Boston, MA, United States
Disclosure information not submitted.
MXD3 as a Determinant of Immunoproliferative Response to Immunotherapy in HNSCC
Sunday, October 12, 2025
8:42 AM - 8:48 AM EDT